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ABSTRACT
CONTEXT AND OBJECTIVE: Chronic kidney disease (CKD) is an escalating medical and socioeconomic 
problem worldwide. Information concerning the causes of CKD, which is a prerequisite for reducing the 
disease burden, is sparse in Malaysia. Therefore, this study aimed to evaluate the attributable causes of CKD 
in an adult population at a tertiary referral hospital.
DESIGN AND SETTING: Retrospective study at Hospital Universiti Sains Malaysia (HUSM). 
METHODS: This was an analysis based on medical records of adult patients at HUSM. Data regarding de-
mographics, laboratory investigations, attributable causes and CKD stage were gathered.
RESULTS: A total of 851 eligible cases were included. The patients’ mean age was 61.18 ± 13.37 years. CKD 
stage V was found in 333 cases (39.1%) whereas stages IV, IIIb, IIIa, and II were seen in 240 (28.2%), 186 (21.9%), 
74 (8.7%) and 18 (2.1%), respectively. The percentage of CKD stage V patients receiving renal replacement 
therapy was 15.6%. The foremost attributable causes of CKD were diabetic nephropathy (DN) (44.9%), hyper-
tension (HPT) (24.2%) and obstructive uropathy (9.2%). The difference in the prevalence of CKD due to DN, 
HPT and glomerulonephritis between patients ≤ 50 and > 50 years old was statistically significant.
CONCLUSION: Our results suggest that DN and HPT are the major attributable causes of CKD among 
patients at a Malaysian tertiary-care hospital. Furthermore, the results draw attention to the possibility that 
greater emphasis on primary prevention of diabetes and hypertension will have a great impact on reduc-
tion of hospital admissions due to CKD in Malaysia.
RESUMO
CONTEXTO E OBJETIVO: Doença renal crônica (DRC) é um problema médico e socioeconômico crescen-
te. As informações relativas às causas da DRC são pré-requisito para reduzir a carga da doença, e são escas-
sas na Malásia. Este estudo tem como objetivo avaliar as causas atribuíveis à DRC na população adulta de 
um hospital de referência terciária.
TIPO DE ESTUDO E LOCAL: Estudo retrospectivo realizado no Hospital Universiti Sains Malaysia (HUSM).
MÉTODOS: Análise de prontuários de pacientes adultos de HUSM. Foram obtidos dados demográficos, 
exames laboratoriais, causas atribuíveis e estágio da DRC.
RESULTADOS: Um total de 851 casos elegíveis foi incluído. A idade média dos pacientes foi de 61,18 ± 
13,37 anos. DRC fase V foi contabilizada em 333 casos (39,1%), enquanto casos de estágio IV, IIIb, IIIa e II 
foram 240 (28,2%), 186 (21,9%), 74 (8,7%) e 18 (2,1%), respectivamente. A porcentagem de pacientes com 
DRC estágio V recebendo a terapia de substituição renal foi 15,6%. As causas atribuíveis mais importantes 
da DRC foram nefropatia diabética (ND) (44,9%), hipertensão (24,2%) e uropatia obstrutiva (9,2%). A dife-
rença na prevalência da DRC devido à ND, hipertensão e glomerulonefrite entre pacientes ≤ 50 anos e 
> 50 anos de idade foi estatisticamente significativa. 
CONCLUSÃO: Nossos resultados sugerem que a ND e a hipertensão são as principais causas atribuíveis 
da DRC em pacientes sob cuidados terciários na Malásia. Os resultados apontam para a possibilidade de 
maior ênfase na prevenção primária da diabetes e hipertensão como impactante na redução das interna-
ções hospitalares devidas a DRC na Malásia. 
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INTRODUCTION
Chronic kidney disease (CKD) is an overwhelming health and 
socioeconomic problem across the globe. Statistics from the 
United States suggest that for each patient with end-stage renal 
disease (ESRD), there are more than 200 with overt CKD (stages 
III or IV) and nearly 5000 with covert disease (stages I or II).1 
Deplorably, this sort of evidence is sparse for developing 
countries, including Malaysia, where the estimated prevalence of 
CKD is around 9%2 and the prevalence of ESRD patients on dial-
ysis has risen from 325 (year 2001) to 975 (year 2012) per mil-
lion population (pmp). This has been attributed to the escalating 
incidence of diabetic kidney disease, which accounts for more 
than half of new ESRD cases.3 Information regarding the etiology 
of CKD stages I to V is scarce in Malaysia. The published data 
describe only the primary renal disease of ESRD patients.
In one descriptive study by Shaza et al.,4 observations were 
made on 117 ESRD patients receiving treatment at Penang 
General Hospital, Malaysia, over a period of two and a half years 
(January 1, 2000, to June 30, 2002). This revealed that the most 
frequent known causes of ESRD included diabetic nephropathy 
(DN) and glomerulonephritis (GN), whereas unknown etiolo-
gies accounted for 14%. Similarly, Liu and Hooi reported that 
the major known causes of ESRD incidence in 2003 and 2004 
were DN and GN, whereas hypertension (HPT) and obstruc-
tive uropathy (OBS) were among the less common causes.5 They 
also reported that there was higher incidence of ESRD due to 
unknown causes. 
OBJECTIVE
We aimed to describe the demographics, clinical profile and 
possible attributable causes of CKD among adult patients at a 
tertiary-care hospital in Malaysia. 
METHODS
A retrospective study based on the medical records of adult 
patients was conducted at Hospital Universiti Sains Malaysia 
(HUSM), Kota Bharu, Malaysia, which is a tertiary referral 
institute located in the state capital of Kelantan. This state has 
an estimated population of 1.68 million (0.85 million males 
and 0.84 million females).6 HUSM has 33 inpatient units 
(wards) with a total capacity of 769 beds, and 12 specialist out-
patient clinics, including the CKD Resource Centre. The latter 
serves not only for treatments but also for providing aware-
ness, knowledge and pre-dialysis education to CKD patients 
from all over the northeast of the Malaysian Peninsula (states 
of Kelantan, Terengganu and Pahang). 
Permission to conduct this study was acquired from the 
Human Research Ethics Review Committee, Universiti Sains 
Malaysia. Medical records (paper-based records) of adult patients 
(age ≥ 18 years) either seen in the CKD Resource Centre or admit-
ted to HUSM due to CKD, between January 2009 and December 
2013, were eligible for inclusion in the study. Medical records relat-
ing to patients with acute kidney injury, patients with acute dete-
rioration on chronic kidney disease with insufficient information 
to confirm the attributable cause and/or stage of CKD and patients 
aged < 18 years were excluded. 
The researcher extracted the data from the medical records 
between January and May 2014. An average of 20 medical files 
were reviewed per day and information regarding demograph-
ics, laboratory findings, patient’s medical history, family history of 
diseases, ultrasound or X-ray results relating to kidney, ureter and 
bladder (KUB), chest radiograph results, types of renal replace-
ment therapy and probable cause of the disease were gathered.
Criteria for assessment of the attributable  
causes of chronic kidney disease
The attributable causes of CKD were assessed using the diag-
nosis that had been made by the nephrologist or clinician. If this 
was unavailable, the criteria described below were used to deter-
mine the probable cause of CKD.
DN was considered to be the underlying cause of CKD if a 
patient had a confirmed diagnosis of diabetes mellitus (DM) and 
any of the following criteria: long-standing DM before the onset 
of CKD (minimum 10 years), evidence of substantial protein-
uria, presence of diabetic retinopathy and normal-sized kidneys 
on ultrasound.7
HPT was diagnosed as a cause of CKD if a patient had any 
of the following conditions: long history of hypertension predat-
ing renal impairment (minimum of five years), presence of left 
ventricular hypertrophy or hypertensive retinopathy and no sub-
stantiation of any other etiology of kidney disease.8
Patients with chronic renal failure who had pathological pro-
teinuria and normal or small kidneys and who ultimately devel-
oped end-stage renal disease (ESRD) with small kidneys were 
categorized as cases of chronic glomerulonephritis, whether or 
not a biopsy had been obtained.9
The procedures used for diagnosing obstructive uropathy 
(OBS) were KUB ultrasound, KUB radiography, cystoscopy, 
intravenous pyelography, retrograde pyelography and radioiso-
tope renography. This diagnosis was made if the patient had solid 
evidence of urinary obstruction (nephrolithiasis, ureterolithia-
sis, cystolithiasis, benign prostatic hyperplasia, urethral stricture, 
etc.), with or without hematuria and presence of hydronephrosis 
and hydroureter.
Chronic pyelonephritis (CPN) was considered to be the pos-
sible underlying etiology of CKD if a patient had a history of 
recurrent or persistent urinary tract infections and noticeable 
renal scarring.9
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The diagnosis of adult polycystic kidney disease (APKD) was 
made if a patient had enlarged or palpable kidneys with bilateral 
complex renal cysts, with or without a family history of polycys-
tic kidney disease and a history of flank pain.
Toxic nephropathy was considered to be the presumptive 
cause of CKD if a patient had a strong history of use of nephro-
toxic agents (e.g. nonsteroidal anti-inflammatory drugs (NSAIDs), 
traditional medicines etc.) and in the absence of indicators of any 
other etiology of kidney disease.
Patients who were diagnosed with or presented CKD for the first 
time, for which no apparent cause could be found, were categorized 
as having disease of unknown cause. Other attributable causes were 
diagnosed on the basis of kidney imaging, renal Doppler ultraso-
nography, renal angiography and renal biopsy results. 
The CKD was classified based on the estimated glomerular 
filtration rate (GFR) as per the Kidney Disease Improving Global 
Outcomes (KDIGO) guidelines.10 The GFR was calculated by 
using the Chronic Kidney Disease Epidemiology Collaboration 
(CKD-EPI) equation.11 
The data are presented as mean ± standard deviation (SD) for 
continuous variables and numbers and/or percentages for cate-
gorical variables. The data were analyzed according to age groups 
(≤ 50 or > 50 years of age) and gender. Comparisons of categori-
cal and continuous variables were assessed by means of the chi-
square test and t test, respectively. Variables that were not avail-
able for a large proportion of the sample were not included in 
the final analysis. The analyses were carried out by using the 
Statistical Package for the Social Sciences (SPSS version 20, 
Chicago, IL, USA) for Windows. A P-value < 0.05 was consid-
ered statistically significant.
RESULTS
The total numbers of patients admitted to and visiting HUSM 
during 2009-2013 are shown in Table 1. Eight hundred and fifty-
one eligible cases (541 males and 310 females) were included 
in the present study. The sociodemographic data are shown in 
Table 2. The patients’ mean age was 61.18 ± 13.37 years (range 
18-92), with preponderance of patients (32.4%) in the age group 
of 60-69 years and only 3.2% in the age group of 18-29 years. 
There was predominance of Malay race (95.9%), while Chinese, 
Indian and other races constituted the minority. Approximately 
91% of our cases were from the state of Kelantan and 69.2% were 
from urban areas. It was found that 7.4% of the patients were cur-
rent smokers, while 30.7% were former smokers. Twenty-three 
patients (2.7%) had a family history of CKD, whereas family his-
tories of DM, hypertension and heart disease were noticed in 
13.3%, 10.6% and 7.9% of the patients, respectively. There were 
98 cases with histories of urolithiasis. Among all the patients, 
21.5% were chronic users of nonsteroidal anti-inflammatory 
drugs (NSAIDs) and 3.5% self-reported use of traditional medi-
cine. The mean estimated GFR was 23.16 ± 16.71 ml/min/1.73m2, 
as calculated using the CKD-EPI equation. Using the KDIGO 
classification for CKD staging, we found that our patients were 
predominantly in the late stages of CKD (stages IV and V).
A&E = Accident & Emergency Department; FCC = Family Care Clinic; RME = Rapid Medical Evaluation; CKD = Chronic Kidney Disease Resource Centre.
Table 1. Patient population at Hospital Universiti Sains Malaysia between 2009 and 2013
Patient population 2009 2010 2011 2012 2013 Total
Outpatients 356077 343251 332330 347698 353082 1732438
A&E 57447 56522 56799 59484 63349
FCC + RME 82720 77574 68655 64570 66363
Staff 19106 19657 18311 16803 17145
General medicine 35353 31620 33147 28833 28105
Surgery 22009 21418 21274 21190 20,683
Pediatrics 8674 8585 8730 8727 9715
Obstetrics 13577 12007 10333 10860 10099
Gynecology 5845 5653 5754 5191 4731
Orthopedics 23869 23669 24020 25446 24735
Psychiatry 8543 8804 8871 9107 8936
Ophthalmology 16865 17725 19605 20540 20924
Otorhinolaryngology 17371 18411 18005 18992 18329
Dentistry 41528 37686 32543 40576 41313
Oncology 3170 3920 6283 16443 15915
CKD -- -- -- 436 1157
Audiology & speech pathology unit -- -- -- -- 943
Dietetics -- -- -- 211 386
Transfusion medicine -- -- -- 289 254
Inpatients 35962 36627 34915 37311 37644 182459
Total 392039 379878 367245 385009 390276 1914897
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Table 2. Patients’ demographic data obtained from the sample 
CKD = chronic kidney disease; DM = diabetes mellitus; HPT = hypertension; HD = heart disease; NSAID = nonsteroidal anti-inflammatory drug.
Demographics n (%) Overall (n = 851) Male (n = 541) Female (n = 310) P-value*
Age group (years) 
18-29 27 (3.2) 18 (3.3) 9 (2.9)
0.867
30-39 25 (2.9) 13 (2.4) 12 (3.9)
40-49 76 (8.9) 45 (8.3) 31 (10.0)
50-59 215 (25.3) 137 (25.3) 78 (25.2)
60-69 276 (32.4) 180 (33.3) 96 (31.0)
70-79 174 (20.4) 111 (20.5) 63 (20.3)
≥ 80 58 (6.8) 37 (6.8) 21 (6.8)
Race
Malay 816 (95.9) 520 (96.1) 296 (95.9)
0.952
Chinese 29 (3.4) 17 (3.1) 12 (3.9)
Indian 3 (0.4) 2 (0.4) 1 (0.3)
Others 3 (0.4) 2 (0.4) 1 (0.3)
Stratum
Urban 589 (69.2) 381 (70.4) 102 (32.9)
0.317
Rural 262 (30.8) 160 (29.6) 208 (67.1)
Profession/Occupation
Employed 77 (9.0) 62 (11.5) 15 (4.8)
< 0.001
Unemployed 185 (21.7) 92 (17.0) 94 (30.3)
Self-employed 203 (23.9) 187 (34.6) 16 (5.2)
Retired/Pensioner 228 (26.8) 193 (35.7) 35 (11.3)
Student 11 (1.3) 7 (1.3) 4 (1.3)
Housewife 147 (17.3) -- 146 (47.1)
Smoking status
Current smoker 63 (7.4) 57 (10.5) 6 (1.9)
< 0.001Former smoker 261 (30.7) 242 (44.7) 19 (6.1)
Never smoked 527 (61.9) 242 (44.7) 285 (91.9)
Family history of CKD
Yes 23 (2.7) 14 (2.6) 9 (2.9)
0.828
No 828 (97.3) 527 (97.4) 301 (97.1)
Family history of DM
Yes 113 (13.3) 71 (13.1) 42 (13.5)
0.916
No 738 (86.7) 470 (86.9) 268 (86.5)
Family history of HPT 
Yes 90 (10.6) 56 (10.4) 34 (11.0)
0.817
No 761 (89.4) 485 (89.6) 276 (89.0)
Family history of HD
Yes 67 (7.9) 50 (9.2) 17 (5.5)
0.063
No 784 (92.1) 491 (90.8) 293 (94.5)
History of urolithiasis
Yes 98 (11.5) 78 (14.4) 20 (6.5)
< 0.001
No 753 (88.5) 463 (85.6) 290 (93.5)
History of chronic NSAID use
Yes 183 (21.5) 136 (25.1) 47 (15.2) 0.001
No 668 (78.5) 405 (74.6) 263 (84.8)
Traditional medicine
Yes 30 (3.5) 23 (4.3) 7 (2.3)
0.176
No 821 (96.5) 518 (95.7) 303 (97.7)
CKD severity 
Stage II 18 (2.1) 15 (2.8) 15 (2.8)
0.002
Stage IIIa 74 (8.7) 56 (10.4) 56 (10.4)
Stage IIIb 186 (21.9) 132 (24.4) 132 (24.4)
Stage IV 240 (28.2) 141 (26.1) 141 (26.1)
Stage V 333 (39.1) 197 (36.4) 197 (36.4)
Albumin (g/l; mean ± SD) 36.33 ± 6.67 36.98 ± 6.62 35.20 ± 6.61 < 0.001
Hemoglobin (g/dl; mean ± SD) 10.35 ± 2.53 10.71 ± 2.57 9.72 ± 2.33 < 0.001
Potassium (mmol/l; mean ± SD) 4.51 ± 0.90 4.52 ± 0.92 4.50 ± 0.87 0.726
Calcium (mmol/l; mean ± SD) 2.21 ± 0.27 2.22 ± 0.27 2.20 ± 0.27 0.431
Phosphate (mmol/l; mean ± SD) 1.47 ± 0.62 1.44 ± 0.60 1.53 ± 0.63 0.045
Calcium × phosphorus (mmol2/l2; mean ± SD) 3.20 ± 1.23 3.14 ± 1.19 3.32 ± 1.29 0.045
Creatinine (µmol; mean ± SD) 410.23 ± 365.97 401.99 ± 369.35 413.25 ± 359.35 0.840
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The majority of the patients were asymptomatic. However, 
the chief complaints at presentation were nausea (20.9%), vom-
iting (15.3%), lethargy (52.6%), malaise (52.9%), edema (36.1%), 
poor appetite (50.3%), weight loss (11.6%), dyspnea (34.7%), 
decreased urine output/oliguria (10.8%) and dysuria (5.1%). 
The most frequent attributable cause of CKD was DN (44.9%), 
followed by HPT (24.2%) and OBS (9.2%), as shown in Table 3. 
The cause of CKD was unknown in 9.4% of our cases. Out of 
57 patients with glomerular disease, five had focal segmental glo-
merulosclerosis (FSGS), two had IgA nephropathy, five had lupus 
nephritis (LN) and the rest had chronic glomerulonephritis. Of the 
seven in the miscellaneous group, two patients had CKD due to 
renal tubular acidosis (one patient with distal tubular acidosis and 
another one with proximal tubular acidosis), one had renal artery 
stenosis, three had congenital urogenital malformations and one 
had CKD due to trauma/injury to the kidneys. 
There was a substantial statistical difference in the prevalence 
of CKD due to DN between younger patients and older patients 
(34.9% versus 47.0%; P = 0.008). Similarly, the difference in prev-
alence of CKD due to GN and HPT between the younger and 
older age groups was statistically significant (29.5% versus 2.0%; 
P < 0.001; and 6.2% versus 27.9%; P < 0.001, respectively). The 
differences in the prevalence of CKD between male and female 
patients, due to DN (41.2% versus 51.3%; P = 0.004), APKD 
(3.3% versus 0.3%; P = 0.004) and unknown cause (11.5% versus 
5.8%; P = 0.007), were also statistically significant.
The attributable causes of CKD in the urban and rural zones 
are depicted in Figure 1. These results showed that the place 
where the patients lived (rural or urban areas) had no statisti-
cal influence on the prevalence of CKD due to any of the etiolo-
gies. Increased renal parenchymal echogenicity was the leading 
ultrasound abnormality (43.5%), while atrophic kidneys were 
seen in 17.6% of the patients. Increased cardiothoracic ratio 
(cardiomegaly) was found in 52.6% of the subjects. Only 8.1% 
and 3.9% of the patients had pleural effusion and pulmonary 
edema, respectively. 
Renal replacement therapy, consisting of either hemodial-
ysis (HD) or peritoneal dialysis (PD), was used in 134 patients 
(15.6%). Among these patients, HD was the most frequent type 
of treatment (93.3%), while continuous ambulatory PD was used 
much less frequently (6.7%). None of the patients received con-
tinuous cycling peritoneal dialysis or kidney transplants. In our 
centre, the majority of the patients decide themselves which type 
of renal replacement therapy they want. To help these patients 
to decide, pre-dialysis talks are held at the Chronic Kidney 
Disease Resource Centre, Hospital Universiti Sains Malaysia. 
After patients acquire all the information about types of renal 
replacement therapy, they choose their treatment. Patients who 
are interested in kidney transplantation are referred to Hospital 
Kuala Lumpur.
DISCUSSION
Our main results showed that most of the patients with CKD in 
the sample were men and older people with advanced chronic 
kidney disease (stages IV and V). Beyond that, the most frequent 
attributable causes of CKD in the sample were DN and HPT. 
Table 3. Attributable causes of chronic kidney disease in the sample
*Significant difference (P < 0.05) between age categories; †significant difference (P < 0.05) between male and female.
Etiology n (%) Overall ≤ 50 years > 50 years Male Female
Glomerulonephritis* 57 (6.7) 43 (29.5) 14 (2.0) 30 (5.5) 27 (8.7)
Diabetic nephropathy*† 382 (44.9) 51 (34.9) 331 (47.0)) 223 (41.2) 159 (51.3)
Hypertension* 206 (24.2) 9 (6.2) 197 (27.9) 134 (24.8) 72 (23.2)
Adult polycystic kidney disease† 19 (2.2) 5 (3.4) 14 (2.0) 18 (3.3) 1 (0.3)
Obstructive uropathy 78 (9.2) 13 (8.9) 65 (9.2) 51 (9.4) 27 (8.7)
Chronic pyelonephritis* 4 (0.5) 3 (2.1) 1 (0.1) 2 (0.4) 2 (0.6)
Toxic nephropathy 18 (2.1) 5 (3.4) 13 (1.8) 15 (2.8) 3 (1.0)
Miscellaneous 7 (0.8) 7 (0.8) -- 6 (1.1) 1 (0.3)
Unknown† 80 (9.4) 10 (6.8) 70 (9.9) 62 (11.5) 18 (5.8)
Total 851 (100) 146 (100) 705 (100) 541 (100) 310 (100)
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Figure 1. Attributable causes of chronic kidney disease in 
rural and urban areas. 
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The mean age of the patients in the present study was sim-
ilar to that of previous reports.12,13 Higher prevalence of CKD 
in the elderly population has been attributed to the fact that 
renal function declines with age.14 The ethnic composition of 
Malaysia is Bumiputera (Malay) (67.4%), Chinese (24.6%), 
Indian (7.3%) and others (0.7%).15 However, the predominance 
of Malay patients (95.9%) in our study population was because 
the majority of our patients were from the states of Kelantan and 
Terengganu in Malaysia, where the dominant ethnic group is 
Malay. The higher percentage of former smokers and lower per-
centage of current smokers in the present study was because the 
CKD patients were advised to quit smoking, given that it causes 
rapid progression of kidney disease.16 The level of chronic NSAID 
use (21.5%) in the current study was slightly higher and the level 
of traditional medicine use (3.5%) was lower than that reported 
previously.2 This history of higher NSAID use might be associ-
ated with gout (16.3%). A gender-based comparison of demo-
graphics revealed that there was no significant difference in 
age groups, race and habitation between male and female CKD 
patients. These findings demonstrated that the abovementioned 
factors had no impact on the prevalence of CKD among male 
and female patients. The majority of the patients were in the late 
stages of CKD at the time of presentation to the study setting. 
Similar to these findings, Al-Ramahi also found higher preva-
lence of CKD stage V subjects in their study conducted at Penang 
General Hospital, Malaysia.13 The higher prevalence of the late 
stages of CKD might be attributable either to late nephrology refer-
ral by primary care physicians or lack of awareness among patients 
themselves, regarding the proper time to seek medical attention. 
Regarding the preferred types of dialysis, PD is the favor-
ite treatment method in Mexico17 and Hong Kong,18 but HD 
is the major mode of treatment in various countries including 
Malaysia.19-21 Consistent with these findings, we also observed 
that the majority of ESRD patients preferred HD over PD. 
In Malaysia, PD is underutilized, notwithstanding the efforts of 
the Malaysian government to promote this treatment method. 
This can mainly attributed to the abundance of HD centers pro-
vided by the private sector and non-governmental organiza-
tions (NGOs), as well as the better survival rates among HD 
patients.21 None of our patients received continuous cycling 
peritoneal dialysis or kidney transplants, which might have 
been due to financial constraints. 
DN was the foremost attributable cause of CKD in our 
study population, and this finding is similar to previous reports 
regarding the causes of CKD (stages III to V).7,8 The second lead-
ing cause of CKD was HPT (24.2%), and the occurrence rate of 
HPT was higher than that reported in Sri Lanka.7,8 This finding 
demonstrates that there is a need to improve the management 
of hypertension, since this is a major contributor not only to 
renal disease and its progression towards ESRD but also to car-
diovascular morbidity and mortality.22 The percentage of GN in 
our study was less than the previously reported 9.9% to 12%.7,8 
This may have been because infectious diseases are more preva-
lent in countries of low economic level, given their poor sanita-
tion, insufficient supply of safe water and greater concentrations 
of disease-transmitting vectors.23 The prevalence of kidney dis-
ease due to nephrotoxic drugs was 2.1%, which reflects the need 
for awareness and proper knowledge in relation to excessive use 
of these agents. The cause of CKD was unknown in 9.4% of the 
patients, which was comparable to the findings of a recent report.8 
However, this rate was considerably less than that reported by 
Gooneratne et al.7 and Athuraliya et al.24 The decline in the prev-
alence of unknown causes may have been due to better diagnos-
tic work-up, thus resulting in a greater number of patients diag-
nosed with an exact cause for their disease, such as glomerular 
diseases, heredofamilial causes and toxic nephropathy. 
DN and HPT were the leading contributors towards CKD in 
the older age category (47.0% and 27.9%, respectively). The dif-
ferences in the frequencies of CKD due to DN and HPT between 
the younger and older age groups were statistically significant, 
and this finding was comparable to the results from another 
study conducted in an Asian country.8 Gender-related differences 
in health habits or lifestyle may cause differences in the risk fac-
tors for developing DM and, consequently, may cause variations 
in DM prevalence between men and women.25 Previous studies 
have also shown that the prevalence of DM is higher in the female 
than in the male population.26,27 This might be the reason why the 
prevalence of CKD due to DN was significantly higher among 
females than among males in the current study. The frequency 
of GN was considerably higher in the younger than in the older 
age category (P < 0.001), which was similar to the findings of 
Wijewickrama et al.8
Although we achieved the desired objectives of our study, it 
had some limitations. Firstly, this study was conducted in a single 
tertiary referral hospital in the northeast of the Malaysian penin-
sula and only 2.2% of the patients were from outside the north-
eastern region. Therefore, our results may not give a clear picture 
of attributable causes of CKD throughout Malaysia. Secondly, 
due to the predominance of the Malay ethnic group, the find-
ings of this study cannot be generalized to the overall Malaysian 
population. Thirdly, due to the retrospective nature of this study, 
some data were not fully available: for example, income sta-
tus, health-seeking behavioral patterns, distance to the health-
care facility and ability to afford transportation. However, this 
may not have significantly influenced the results. Lastly, we did 
not use a probability sampling method, e.g. random sampling, 
and therefore we had disadvantages such as selection bias and 
non-generalizability.
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This study recommends that emphasis is required at two lev-
els: firstly, identification of individuals at risk of CKD develop-
ment or presenting early CKD, as soon as possible; and secondly, 
early referral of CKD patients to nephrology centers by primary 
care physicians. This second approach has already demonstrated 
improvements in treatment outcomes, and it results in earlier 
preparation of the start of dialysis.28 Moreover, education pro-
grams and seminars need to be conducted in order to increase 
awareness among CKD patients regarding dietary habits, neph-
rotoxic agents, smoking cessation and choice of types of renal 
replacement therapy etc. 
CONCLUSION
The data suggest that DN and HPT are the major attributable causes 
of Chronic Kidney Disease among patients at a tertiary referral hos-
pital in the northeast of the Malaysian peninsula. Although the 
results cannot be easily generalized to the general population, the 
study draws attention to the possibility that greater emphasis on 
primary prevention of diabetes and hypertension will have a large 
impact on reduction of hospital admissions due to CKD in Malaysia.
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